nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—CYP2E1—liver cancer	0.299	0.503	CbGaD
Theophylline—CYP1A1—liver cancer	0.295	0.497	CbGaD
Theophylline—CYP1B1—Doxorubicin—liver cancer	0.075	0.366	CbGbCtD
Theophylline—CYP2C8—Sorafenib—liver cancer	0.0313	0.153	CbGbCtD
Theophylline—CYP1A2—Sorafenib—liver cancer	0.0242	0.118	CbGbCtD
Theophylline—CYP2C9—Sorafenib—liver cancer	0.0218	0.107	CbGbCtD
Theophylline—CYP2D6—Sorafenib—liver cancer	0.02	0.0974	CbGbCtD
Theophylline—CYP3A4—Sorafenib—liver cancer	0.0127	0.062	CbGbCtD
Theophylline—CYP2D6—Doxorubicin—liver cancer	0.0121	0.0591	CbGbCtD
Theophylline—CYP3A4—Doxorubicin—liver cancer	0.00771	0.0376	CbGbCtD
Theophylline—Caffeine—PIK3CB—liver cancer	0.00218	0.253	CrCbGaD
Theophylline—Caffeine—PIK3CD—liver cancer	0.00218	0.253	CrCbGaD
Theophylline—Caffeine—PIK3CA—liver cancer	0.00169	0.196	CrCbGaD
Theophylline—Rhabdomyolysis—Sorafenib—liver cancer	0.00135	0.0342	CcSEcCtD
Theophylline—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.00132	0.0335	CcSEcCtD
Theophylline—Aminophylline—CYP2E1—liver cancer	0.0011	0.128	CrCbGaD
Theophylline—Sinus tachycardia—Epirubicin—liver cancer	0.0011	0.0278	CcSEcCtD
Theophylline—Sinus tachycardia—Doxorubicin—liver cancer	0.00101	0.0257	CcSEcCtD
Theophylline—Dermatitis exfoliative—Sorafenib—liver cancer	0.000918	0.0233	CcSEcCtD
Theophylline—Venous thrombosis—Epirubicin—liver cancer	0.000817	0.0207	CcSEcCtD
Theophylline—Abdominal pain upper—Sorafenib—liver cancer	0.000792	0.0201	CcSEcCtD
Theophylline—Hypokalaemia—Sorafenib—liver cancer	0.000789	0.02	CcSEcCtD
Theophylline—Venous thrombosis—Doxorubicin—liver cancer	0.000756	0.0192	CcSEcCtD
Theophylline—Theobromine—CYP2E1—liver cancer	0.000732	0.0848	CrCbGaD
Theophylline—Hypercalcaemia—Epirubicin—liver cancer	0.000635	0.0161	CcSEcCtD
Theophylline—Haematemesis—Epirubicin—liver cancer	0.000635	0.0161	CcSEcCtD
Theophylline—Ventricular arrhythmia—Epirubicin—liver cancer	0.000596	0.0151	CcSEcCtD
Theophylline—Albuminuria—Epirubicin—liver cancer	0.000591	0.015	CcSEcCtD
Theophylline—Haematemesis—Doxorubicin—liver cancer	0.000588	0.0149	CcSEcCtD
Theophylline—Hypercalcaemia—Doxorubicin—liver cancer	0.000588	0.0149	CcSEcCtD
Theophylline—Flushing—Sorafenib—liver cancer	0.000556	0.0141	CcSEcCtD
Theophylline—Ventricular arrhythmia—Doxorubicin—liver cancer	0.000552	0.014	CcSEcCtD
Theophylline—Albuminuria—Doxorubicin—liver cancer	0.000547	0.0139	CcSEcCtD
Theophylline—Arrhythmia—Sorafenib—liver cancer	0.000536	0.0136	CcSEcCtD
Theophylline—Alopecia—Sorafenib—liver cancer	0.00053	0.0134	CcSEcCtD
Theophylline—Extravasation—Epirubicin—liver cancer	0.000506	0.0128	CcSEcCtD
Theophylline—Ventricular extrasystoles—Epirubicin—liver cancer	0.000489	0.0124	CcSEcCtD
Theophylline—Hyperuricaemia—Epirubicin—liver cancer	0.000476	0.0121	CcSEcCtD
Theophylline—Extravasation—Doxorubicin—liver cancer	0.000468	0.0119	CcSEcCtD
Theophylline—Ventricular extrasystoles—Doxorubicin—liver cancer	0.000452	0.0115	CcSEcCtD
Theophylline—Blood uric acid increased—Epirubicin—liver cancer	0.000449	0.0114	CcSEcCtD
Theophylline—Hyperuricaemia—Doxorubicin—liver cancer	0.00044	0.0112	CcSEcCtD
Theophylline—Dermatitis contact—Epirubicin—liver cancer	0.000436	0.011	CcSEcCtD
Theophylline—Anaphylactic shock—Sorafenib—liver cancer	0.000426	0.0108	CcSEcCtD
Theophylline—Infection—Sorafenib—liver cancer	0.000423	0.0107	CcSEcCtD
Theophylline—Shock—Sorafenib—liver cancer	0.000419	0.0106	CcSEcCtD
Theophylline—Nervous system disorder—Sorafenib—liver cancer	0.000418	0.0106	CcSEcCtD
Theophylline—Blood uric acid increased—Doxorubicin—liver cancer	0.000416	0.0105	CcSEcCtD
Theophylline—Anorexia—Sorafenib—liver cancer	0.000406	0.0103	CcSEcCtD
Theophylline—Dermatitis contact—Doxorubicin—liver cancer	0.000403	0.0102	CcSEcCtD
Theophylline—Coma—Epirubicin—liver cancer	0.000403	0.0102	CcSEcCtD
Theophylline—Caffeine—CYP2E1—liver cancer	0.000376	0.0436	CrCbGaD
Theophylline—Coma—Doxorubicin—liver cancer	0.000373	0.00945	CcSEcCtD
Theophylline—Phlebitis—Epirubicin—liver cancer	0.000372	0.00942	CcSEcCtD
Theophylline—Caffeine—CYP1A1—liver cancer	0.000371	0.043	CrCbGaD
Theophylline—Decreased appetite—Sorafenib—liver cancer	0.00037	0.00938	CcSEcCtD
Theophylline—Gastrointestinal pain—Sorafenib—liver cancer	0.000348	0.00882	CcSEcCtD
Theophylline—Phlebitis—Doxorubicin—liver cancer	0.000344	0.00872	CcSEcCtD
Theophylline—Dermatitis exfoliative—Epirubicin—liver cancer	0.000339	0.0086	CcSEcCtD
Theophylline—Urticaria—Sorafenib—liver cancer	0.000338	0.00857	CcSEcCtD
Theophylline—Abdominal pain—Sorafenib—liver cancer	0.000337	0.00853	CcSEcCtD
Theophylline—Body temperature increased—Sorafenib—liver cancer	0.000337	0.00853	CcSEcCtD
Theophylline—Anaphylactoid reaction—Epirubicin—liver cancer	0.000331	0.00838	CcSEcCtD
Theophylline—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000314	0.00796	CcSEcCtD
Theophylline—Hypersensitivity—Sorafenib—liver cancer	0.000314	0.00795	CcSEcCtD
Theophylline—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000306	0.00776	CcSEcCtD
Theophylline—Pruritus—Sorafenib—liver cancer	0.000301	0.00764	CcSEcCtD
Theophylline—Abdominal pain upper—Epirubicin—liver cancer	0.000293	0.00741	CcSEcCtD
Theophylline—Hypokalaemia—Epirubicin—liver cancer	0.000291	0.00739	CcSEcCtD
Theophylline—Diarrhoea—Sorafenib—liver cancer	0.000291	0.00738	CcSEcCtD
Theophylline—Dizziness—Sorafenib—liver cancer	0.000282	0.00714	CcSEcCtD
Theophylline—Vomiting—Sorafenib—liver cancer	0.000271	0.00686	CcSEcCtD
Theophylline—Abdominal pain upper—Doxorubicin—liver cancer	0.000271	0.00686	CcSEcCtD
Theophylline—Hypokalaemia—Doxorubicin—liver cancer	0.00027	0.00683	CcSEcCtD
Theophylline—Rash—Sorafenib—liver cancer	0.000269	0.0068	CcSEcCtD
Theophylline—Dermatitis—Sorafenib—liver cancer	0.000268	0.0068	CcSEcCtD
Theophylline—Headache—Sorafenib—liver cancer	0.000267	0.00676	CcSEcCtD
Theophylline—Nausea—Sorafenib—liver cancer	0.000253	0.00641	CcSEcCtD
Theophylline—Hyperglycaemia—Epirubicin—liver cancer	0.00025	0.00633	CcSEcCtD
Theophylline—Haematuria—Epirubicin—liver cancer	0.000235	0.00596	CcSEcCtD
Theophylline—Hyperglycaemia—Doxorubicin—liver cancer	0.000231	0.00585	CcSEcCtD
Theophylline—Haematuria—Doxorubicin—liver cancer	0.000218	0.00552	CcSEcCtD
Theophylline—Flushing—Epirubicin—liver cancer	0.000206	0.00521	CcSEcCtD
Theophylline—Arrhythmia—Epirubicin—liver cancer	0.000198	0.00501	CcSEcCtD
Theophylline—Alopecia—Epirubicin—liver cancer	0.000196	0.00496	CcSEcCtD
Theophylline—Flushing—Doxorubicin—liver cancer	0.00019	0.00482	CcSEcCtD
Theophylline—Tension—Epirubicin—liver cancer	0.000189	0.0048	CcSEcCtD
Theophylline—Nervousness—Epirubicin—liver cancer	0.000187	0.00475	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—liver cancer	0.000183	0.00464	CcSEcCtD
Theophylline—Alopecia—Doxorubicin—liver cancer	0.000181	0.00459	CcSEcCtD
Theophylline—Agitation—Epirubicin—liver cancer	0.000177	0.00449	CcSEcCtD
Theophylline—Tension—Doxorubicin—liver cancer	0.000175	0.00444	CcSEcCtD
Theophylline—Nervousness—Doxorubicin—liver cancer	0.000173	0.00439	CcSEcCtD
Theophylline—Palpitations—Epirubicin—liver cancer	0.00017	0.00432	CcSEcCtD
Theophylline—Convulsion—Epirubicin—liver cancer	0.000167	0.00423	CcSEcCtD
Theophylline—Agitation—Doxorubicin—liver cancer	0.000164	0.00416	CcSEcCtD
Theophylline—Anxiety—Epirubicin—liver cancer	0.000164	0.00415	CcSEcCtD
Theophylline—Palpitations—Doxorubicin—liver cancer	0.000158	0.004	CcSEcCtD
Theophylline—Anaphylactic shock—Epirubicin—liver cancer	0.000157	0.00399	CcSEcCtD
Theophylline—Infection—Epirubicin—liver cancer	0.000156	0.00396	CcSEcCtD
Theophylline—Shock—Epirubicin—liver cancer	0.000155	0.00392	CcSEcCtD
Theophylline—Convulsion—Doxorubicin—liver cancer	0.000155	0.00392	CcSEcCtD
Theophylline—Nervous system disorder—Epirubicin—liver cancer	0.000154	0.00391	CcSEcCtD
Theophylline—Tachycardia—Epirubicin—liver cancer	0.000154	0.00389	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—liver cancer	0.000151	0.00384	CcSEcCtD
Theophylline—Anorexia—Epirubicin—liver cancer	0.00015	0.0038	CcSEcCtD
Theophylline—Hypotension—Epirubicin—liver cancer	0.000147	0.00373	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—liver cancer	0.000146	0.00369	CcSEcCtD
Theophylline—Infection—Doxorubicin—liver cancer	0.000145	0.00367	CcSEcCtD
Theophylline—Shock—Doxorubicin—liver cancer	0.000143	0.00363	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—liver cancer	0.000143	0.00362	CcSEcCtD
Theophylline—Insomnia—Epirubicin—liver cancer	0.000142	0.00361	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—liver cancer	0.000142	0.0036	CcSEcCtD
Theophylline—Anorexia—Doxorubicin—liver cancer	0.000139	0.00352	CcSEcCtD
Theophylline—Decreased appetite—Epirubicin—liver cancer	0.000137	0.00347	CcSEcCtD
Theophylline—Hypotension—Doxorubicin—liver cancer	0.000136	0.00345	CcSEcCtD
Theophylline—Insomnia—Doxorubicin—liver cancer	0.000132	0.00334	CcSEcCtD
Theophylline—Gastrointestinal pain—Epirubicin—liver cancer	0.000129	0.00326	CcSEcCtD
Theophylline—Decreased appetite—Doxorubicin—liver cancer	0.000127	0.00321	CcSEcCtD
Theophylline—Urticaria—Epirubicin—liver cancer	0.000125	0.00317	CcSEcCtD
Theophylline—Abdominal pain—Epirubicin—liver cancer	0.000124	0.00315	CcSEcCtD
Theophylline—Body temperature increased—Epirubicin—liver cancer	0.000124	0.00315	CcSEcCtD
Theophylline—Gastrointestinal pain—Doxorubicin—liver cancer	0.000119	0.00302	CcSEcCtD
Theophylline—Hypersensitivity—Epirubicin—liver cancer	0.000116	0.00294	CcSEcCtD
Theophylline—Urticaria—Doxorubicin—liver cancer	0.000116	0.00293	CcSEcCtD
Theophylline—Abdominal pain—Doxorubicin—liver cancer	0.000115	0.00292	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—liver cancer	0.000115	0.00292	CcSEcCtD
Theophylline—Pruritus—Epirubicin—liver cancer	0.000111	0.00282	CcSEcCtD
Theophylline—Diarrhoea—Epirubicin—liver cancer	0.000108	0.00273	CcSEcCtD
Theophylline—Hypersensitivity—Doxorubicin—liver cancer	0.000107	0.00272	CcSEcCtD
Theophylline—Dizziness—Epirubicin—liver cancer	0.000104	0.00264	CcSEcCtD
Theophylline—Pruritus—Doxorubicin—liver cancer	0.000103	0.00261	CcSEcCtD
Theophylline—Vomiting—Epirubicin—liver cancer	0.0001	0.00254	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—liver cancer	9.97e-05	0.00252	CcSEcCtD
Theophylline—Rash—Epirubicin—liver cancer	9.93e-05	0.00251	CcSEcCtD
Theophylline—Dermatitis—Epirubicin—liver cancer	9.92e-05	0.00251	CcSEcCtD
Theophylline—Headache—Epirubicin—liver cancer	9.86e-05	0.0025	CcSEcCtD
Theophylline—Dizziness—Doxorubicin—liver cancer	9.63e-05	0.00244	CcSEcCtD
Theophylline—Nausea—Epirubicin—liver cancer	9.35e-05	0.00237	CcSEcCtD
Theophylline—Vomiting—Doxorubicin—liver cancer	9.26e-05	0.00235	CcSEcCtD
Theophylline—Rash—Doxorubicin—liver cancer	9.18e-05	0.00233	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—liver cancer	9.18e-05	0.00232	CcSEcCtD
Theophylline—Headache—Doxorubicin—liver cancer	9.12e-05	0.00231	CcSEcCtD
Theophylline—Nausea—Doxorubicin—liver cancer	8.65e-05	0.00219	CcSEcCtD
Theophylline—CYP2C8—Metabolism—GOT1—liver cancer	8.45e-06	5.55e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GGT1—liver cancer	8.45e-06	5.55e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—VEGFA—liver cancer	8.4e-06	5.52e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—KRAS—liver cancer	8.4e-06	5.52e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CDKN1B—liver cancer	8.39e-06	5.51e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—STAT3—liver cancer	8.32e-06	5.47e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.32e-06	5.46e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MTOR—liver cancer	8.31e-06	5.46e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CB—liver cancer	8.31e-06	5.46e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—VEGFA—liver cancer	8.3e-06	5.46e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—GSTP1—liver cancer	8.28e-06	5.44e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PSMA4—liver cancer	8.26e-06	5.43e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PSMD10—liver cancer	8.26e-06	5.43e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MYC—liver cancer	8.26e-06	5.42e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TGFB1—liver cancer	8.24e-06	5.41e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CASP3—liver cancer	8.22e-06	5.4e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—STAT3—liver cancer	8.22e-06	5.4e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL2—liver cancer	8.21e-06	5.4e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.21e-06	5.39e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PSMA4—liver cancer	8.19e-06	5.38e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PSMD10—liver cancer	8.19e-06	5.38e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TP53—liver cancer	8.18e-06	5.38e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—HMOX1—liver cancer	8.16e-06	5.36e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTA4—liver cancer	8.15e-06	5.36e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KRAS—liver cancer	8.15e-06	5.35e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.08e-06	5.31e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—GSTM1—liver cancer	8.07e-06	5.3e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CD—liver cancer	8.06e-06	5.3e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GOT2—liver cancer	8.03e-06	5.28e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MYC—liver cancer	8.03e-06	5.28e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KRAS—liver cancer	8.01e-06	5.27e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TGFB1—liver cancer	8.01e-06	5.26e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCND1—liver cancer	8e-06	5.26e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—JUN—liver cancer	7.99e-06	5.25e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GOT2—liver cancer	7.96e-06	5.23e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—ALB—liver cancer	7.96e-06	5.23e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTA2—liver cancer	7.94e-06	5.22e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—HRAS—liver cancer	7.94e-06	5.21e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CTNNB1—liver cancer	7.93e-06	5.21e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—HPGDS—liver cancer	7.85e-06	5.16e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—HRAS—liver cancer	7.83e-06	5.14e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.8e-06	5.13e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CDKN1B—liver cancer	7.8e-06	5.13e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—PIK3CA—liver cancer	7.78e-06	5.11e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MMP9—liver cancer	7.77e-06	5.11e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CDKN1A—liver cancer	7.74e-06	5.09e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MYC—liver cancer	7.73e-06	5.08e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PIK3CA—liver cancer	7.72e-06	5.07e-05	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—AKT1—liver cancer	7.72e-06	5.07e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TGFB1—liver cancer	7.71e-06	5.07e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTA1—liver cancer	7.66e-06	5.03e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CYP1A1—liver cancer	7.65e-06	5.02e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CASP3—liver cancer	7.64e-06	5.02e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MYC—liver cancer	7.64e-06	5.02e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL2—liver cancer	7.63e-06	5.02e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KRAS—liver cancer	7.63e-06	5.01e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TGFB1—liver cancer	7.62e-06	5.01e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—GSTM1—liver cancer	7.6e-06	5e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL6—liver cancer	7.6e-06	4.99e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GSTP1—liver cancer	7.59e-06	4.99e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NAT2—liver cancer	7.58e-06	4.98e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK8—liver cancer	7.56e-06	4.97e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP2E1—liver cancer	7.55e-06	4.96e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL6—liver cancer	7.49e-06	4.92e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP2E1—liver cancer	7.49e-06	4.92e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PIK3CA—liver cancer	7.49e-06	4.92e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—HMOX1—liver cancer	7.48e-06	4.92e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—liver cancer	7.47e-06	4.91e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCND1—liver cancer	7.44e-06	4.89e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—JUN—liver cancer	7.43e-06	4.88e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KRAS—liver cancer	7.42e-06	4.88e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CTNNB1—liver cancer	7.37e-06	4.84e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PIK3CA—liver cancer	7.36e-06	4.84e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALDOB—liver cancer	7.26e-06	4.77e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.25e-06	4.76e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—liver cancer	7.24e-06	4.76e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MMP9—liver cancer	7.22e-06	4.75e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—HRAS—liver cancer	7.2e-06	4.73e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CDKN1A—liver cancer	7.2e-06	4.73e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KRAS—liver cancer	7.14e-06	4.69e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HRAS—liver cancer	7.14e-06	4.69e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—MTHFR—liver cancer	7.13e-06	4.68e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—liver cancer	7.12e-06	4.68e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.11e-06	4.67e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYCS—liver cancer	7.07e-06	4.64e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KRAS—liver cancer	7.06e-06	4.64e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK8—liver cancer	7.03e-06	4.62e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CB—liver cancer	7.03e-06	4.62e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.02e-06	4.61e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PIK3CA—liver cancer	7.01e-06	4.61e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—AKT1—liver cancer	7.01e-06	4.6e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYCS—liver cancer	7.01e-06	4.6e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PSMD10—liver cancer	7e-06	4.6e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PSMA4—liver cancer	7e-06	4.6e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PPARA—liver cancer	6.99e-06	4.6e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—liver cancer	6.98e-06	4.59e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GSTM1—liver cancer	6.97e-06	4.58e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GGT1—liver cancer	6.93e-06	4.56e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GOT1—liver cancer	6.93e-06	4.56e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CRABP1—liver cancer	6.93e-06	4.55e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HRAS—liver cancer	6.93e-06	4.55e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—STAT3—liver cancer	6.91e-06	4.54e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—AKT1—liver cancer	6.91e-06	4.54e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—IL6—liver cancer	6.89e-06	4.53e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GOT1—liver cancer	6.87e-06	4.52e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GGT1—liver cancer	6.87e-06	4.52e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—AKT1—liver cancer	6.85e-06	4.5e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL6—liver cancer	6.83e-06	4.49e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PIK3CA—liver cancer	6.82e-06	4.48e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HRAS—liver cancer	6.81e-06	4.48e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GOT2—liver cancer	6.8e-06	4.47e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—liver cancer	6.78e-06	4.45e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—MTHFR—liver cancer	6.72e-06	4.42e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL6—liver cancer	6.63e-06	4.36e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CYP1A1—liver cancer	6.61e-06	4.34e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—liver cancer	6.6e-06	4.33e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PPARA—liver cancer	6.59e-06	4.33e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PIK3CA—liver cancer	6.56e-06	4.31e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL6—liver cancer	6.52e-06	4.28e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—liver cancer	6.49e-06	4.26e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PIK3CA—liver cancer	6.48e-06	4.26e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HRAS—liver cancer	6.48e-06	4.26e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—STAT3—liver cancer	6.42e-06	4.22e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MYC—liver cancer	6.42e-06	4.22e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TGFB1—liver cancer	6.4e-06	4.21e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP2E1—liver cancer	6.4e-06	4.2e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—AKT1—liver cancer	6.36e-06	4.18e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—liver cancer	6.35e-06	4.17e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HRAS—liver cancer	6.31e-06	4.14e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—AKT1—liver cancer	6.3e-06	4.14e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—liver cancer	6.27e-06	4.12e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTP1—liver cancer	6.23e-06	4.09e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL6—liver cancer	6.21e-06	4.08e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.19e-06	4.07e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTP1—liver cancer	6.17e-06	4.06e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—MTHFR—liver cancer	6.16e-06	4.05e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—HMOX1—liver cancer	6.14e-06	4.04e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—AKT1—liver cancer	6.11e-06	4.02e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—HMOX1—liver cancer	6.09e-06	4e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HRAS—liver cancer	6.07e-06	3.99e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HPGDS—liver cancer	6.06e-06	3.98e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PPARA—liver cancer	6.04e-06	3.97e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL6—liver cancer	6.04e-06	3.97e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—AKT1—liver cancer	6.01e-06	3.95e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HRAS—liver cancer	6e-06	3.94e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CG—liver cancer	5.99e-06	3.94e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYCS—liver cancer	5.99e-06	3.93e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MYC—liver cancer	5.97e-06	3.92e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TGFB1—liver cancer	5.95e-06	3.91e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—liver cancer	5.93e-06	3.9e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.92e-06	3.89e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GGT1—liver cancer	5.87e-06	3.86e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GOT1—liver cancer	5.87e-06	3.86e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL6—liver cancer	5.81e-06	3.82e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PPARG—liver cancer	5.78e-06	3.8e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL6—liver cancer	5.74e-06	3.77e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—AKT1—liver cancer	5.73e-06	3.76e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTM1—liver cancer	5.72e-06	3.76e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTM1—liver cancer	5.67e-06	3.73e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CG—liver cancer	5.65e-06	3.71e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—AKT1—liver cancer	5.57e-06	3.66e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—liver cancer	5.52e-06	3.62e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PIK3CA—liver cancer	5.45e-06	3.58e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PPARG—liver cancer	5.45e-06	3.58e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.43e-06	3.57e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP1A1—liver cancer	5.43e-06	3.57e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PSMA4—liver cancer	5.4e-06	3.55e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PSMD10—liver cancer	5.4e-06	3.55e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP1A1—liver cancer	5.38e-06	3.53e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—AKT1—liver cancer	5.36e-06	3.52e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—AKT1—liver cancer	5.3e-06	3.48e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTP1—liver cancer	5.28e-06	3.47e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—liver cancer	5.27e-06	3.46e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CD—liver cancer	5.27e-06	3.46e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GOT2—liver cancer	5.25e-06	3.45e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—HMOX1—liver cancer	5.2e-06	3.42e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ALB—liver cancer	5.2e-06	3.42e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CG—liver cancer	5.18e-06	3.4e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CA—liver cancer	5.07e-06	3.33e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—MTHFR—liver cancer	5.06e-06	3.32e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HRAS—liver cancer	5.04e-06	3.31e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—MTHFR—liver cancer	5.01e-06	3.3e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PPARG—liver cancer	5e-06	3.28e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CD—liver cancer	4.96e-06	3.26e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PPARA—liver cancer	4.96e-06	3.26e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP2E1—liver cancer	4.94e-06	3.24e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PPARA—liver cancer	4.92e-06	3.23e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—liver cancer	4.9e-06	3.22e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ALB—liver cancer	4.9e-06	3.22e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTM1—liver cancer	4.85e-06	3.19e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL6—liver cancer	4.83e-06	3.17e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HRAS—liver cancer	4.69e-06	3.08e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYCS—liver cancer	4.62e-06	3.04e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP1A1—liver cancer	4.6e-06	3.02e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CB—liver cancer	4.59e-06	3.02e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CD—liver cancer	4.55e-06	2.99e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GOT1—liver cancer	4.53e-06	2.98e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GGT1—liver cancer	4.53e-06	2.98e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ALB—liver cancer	4.49e-06	2.95e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL6—liver cancer	4.49e-06	2.95e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—AKT1—liver cancer	4.45e-06	2.93e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.42e-06	2.9e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CB—liver cancer	4.33e-06	2.84e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—MTHFR—liver cancer	4.29e-06	2.82e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CA—liver cancer	4.28e-06	2.81e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CG—liver cancer	4.25e-06	2.79e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CG—liver cancer	4.21e-06	2.77e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PPARA—liver cancer	4.2e-06	2.76e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—AKT1—liver cancer	4.14e-06	2.72e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PPARG—liver cancer	4.1e-06	2.7e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTP1—liver cancer	4.07e-06	2.68e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PPARG—liver cancer	4.07e-06	2.67e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HMOX1—liver cancer	4.02e-06	2.64e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CB—liver cancer	3.97e-06	2.61e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.78e-06	2.48e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTM1—liver cancer	3.74e-06	2.46e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CD—liver cancer	3.74e-06	2.45e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CD—liver cancer	3.7e-06	2.43e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ALB—liver cancer	3.69e-06	2.42e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ALB—liver cancer	3.66e-06	2.4e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CG—liver cancer	3.6e-06	2.37e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP1A1—liver cancer	3.55e-06	2.33e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—AKT1—liver cancer	3.5e-06	2.3e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PPARG—liver cancer	3.47e-06	2.28e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MTHFR—liver cancer	3.31e-06	2.17e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CB—liver cancer	3.26e-06	2.14e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PPARA—liver cancer	3.24e-06	2.13e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CB—liver cancer	3.23e-06	2.12e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CD—liver cancer	3.17e-06	2.08e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ALB—liver cancer	3.12e-06	2.05e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CA—liver cancer	2.8e-06	1.84e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CG—liver cancer	2.78e-06	1.83e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CB—liver cancer	2.76e-06	1.81e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PPARG—liver cancer	2.68e-06	1.76e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CA—liver cancer	2.64e-06	1.73e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CD—liver cancer	2.44e-06	1.61e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CA—liver cancer	2.42e-06	1.59e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALB—liver cancer	2.41e-06	1.58e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AKT1—liver cancer	2.29e-06	1.5e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AKT1—liver cancer	2.15e-06	1.42e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CB—liver cancer	2.13e-06	1.4e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CA—liver cancer	1.99e-06	1.3e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AKT1—liver cancer	1.98e-06	1.3e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CA—liver cancer	1.97e-06	1.29e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CA—liver cancer	1.68e-06	1.11e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKT1—liver cancer	1.62e-06	1.07e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKT1—liver cancer	1.61e-06	1.06e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKT1—liver cancer	1.37e-06	9.03e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CA—liver cancer	1.3e-06	8.53e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKT1—liver cancer	1.06e-06	6.97e-06	CbGpPWpGaD
